Establishment Financial Statements From 2010 to 2024

ESTA Stock  USD 46.07  0.50  1.10%   
Establishment Labs financial statements provide useful quarterly and yearly information to potential Establishment Labs Holdings investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Establishment Labs financial statements helps investors assess Establishment Labs' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Establishment Labs' valuation are summarized below:
Gross Profit
106.6 M
Profit Margin
(0.46)
Market Capitalization
1.3 B
Enterprise Value Revenue
9.6059
Revenue
153.1 M
We have found one hundred twenty available fundamental signals for Establishment Labs Holdings, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to verify all of Establishment Labs Holdings prevailing market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road. The current year's Market Cap is expected to grow to about 706.4 M, whereas Enterprise Value is forecasted to decline to about 732.2 M.

Establishment Labs Total Revenue

92.04 Million

Check Establishment Labs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Establishment Labs' main balance sheet or income statement drivers, such as Interest Income of 568 K, Interest Expense of 9.4 M or Selling General Administrative of 74 M, as well as many indicators such as Price To Sales Ratio of 3.81, Dividend Yield of 0.0 or PTB Ratio of 37.83. Establishment financial statements analysis is a perfect complement when working with Establishment Labs Valuation or Volatility modules.
  
Check out the analysis of Establishment Labs Correlation against competitors.

Establishment Labs Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding21.8 M25.6 M15.3 M
Slightly volatile
Total Assets150.6 M268.6 M94.9 M
Slightly volatile
Short and Long Term Debt Total201.8 M192.2 M69.7 M
Slightly volatile
Other Current Liabilities14.5 M12.8 M11.2 M
Slightly volatile
Total Current Liabilities30.6 M57.1 M44.2 M
Slightly volatile
Other Liabilities1.4 M1.5 M2.7 M
Pretty Stable
Property Plant And Equipment Net84.6 M80.6 M26.3 M
Slightly volatile
Current Deferred Revenue1.5 M1.8 M1.3 M
Pretty Stable
Accounts Payable43.7 M41.6 M13.8 M
Slightly volatile
Cash47.6 M40 M26.4 M
Slightly volatile
Non Current Assets Total98.4 M93.7 M31.9 M
Slightly volatile
Non Currrent Assets Other4.9 M4.7 M1.6 M
Slightly volatile
Other Assets785.7 K1.5 M1.1 M
Slightly volatile
Cash And Short Term Investments47.6 M40 M26.4 M
Slightly volatile
Net Receivables25.6 M46.9 M16.8 M
Slightly volatile
Good Will482.6 K534.8 K372.8 K
Slightly volatile
Common Stock Total Equity156.9 M257.2 M97 M
Slightly volatile
Liabilities And Stockholders Equity150.6 M268.6 M94.9 M
Slightly volatile
Non Current Liabilities Total202.8 M193.1 M52.5 M
Slightly volatile
Capital Surpluse60.3 M57.4 M21.1 M
Slightly volatile
Inventory83.9 M79.9 M23.5 M
Slightly volatile
Other Current Assets5.6 MM3.3 M
Slightly volatile
Total Liabilities262.8 M250.2 M98.7 M
Slightly volatile
Deferred Long Term Liabilities880 K990 K1.1 M
Slightly volatile
Property Plant And Equipment Gross101.8 M96.9 M28.6 M
Slightly volatile
Short and Long Term Debt24.9 M21.7 M30.5 M
Slightly volatile
Total Current Assets112.4 M174.9 M67 M
Slightly volatile
Non Current Liabilities Other139.7 K147 K13.1 M
Slightly volatile
Short Term Debt734.4 K773 K20 M
Slightly volatile
Intangible Assets4.6 MM3.4 M
Slightly volatile
Common Stock180.7 M315.6 M102.5 M
Slightly volatile
Property Plant Equipment61.7 M58.8 M22.9 M
Slightly volatile
Long Term Debt198.2 M188.7 M49.3 M
Slightly volatile
Net Invested Capital127.1 M207.1 M71.3 M
Slightly volatile
Long Term Debt Total38.8 M55.4 M32.5 M
Slightly volatile
Capital Stock232.1 M315.6 M177.6 M
Slightly volatile
Capital Lease Obligations2.5 M3.5 M1.1 M
Slightly volatile

Establishment Labs Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Income568 K541 K542.6 K
Slightly volatile
Selling General Administrative74 M143.5 M46.9 M
Slightly volatile
Total Revenue92 M165.2 M59.5 M
Slightly volatile
Gross Profit58.1 M107 M37.2 M
Slightly volatile
Cost Of Revenue34 M58.2 M22.3 M
Slightly volatile
Tax Provision3.4 M3.2 M830.8 K
Slightly volatile
Other Operating Expenses136.4 M230.2 M89.5 M
Slightly volatile
Research Development16 M26.4 M9.9 M
Slightly volatile
Total Operating Expenses98.8 M172 M64.9 M
Slightly volatile
Reconciled Depreciation3.9 M4.6 M2.8 M
Slightly volatile

Establishment Labs Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation8.8 M14.4 M6.1 M
Slightly volatile
Begin Period Cash Flow42.8 M66.4 M25.7 M
Slightly volatile
Other Cashflows From Financing Activities1.6 M1.7 M23.9 M
Slightly volatile
Depreciation3.5 M4.9 M2.2 M
Slightly volatile
Other Non Cash Items8.2 M8.6 M5.8 M
Slightly volatile
Capital Expenditures12.3 M24.5 M11 M
Slightly volatile
Total Cash From Financing Activities58.1 M86.2 M40.1 M
Slightly volatile
End Period Cash Flow47.6 M40 M26.4 M
Slightly volatile
Dividends Paid3.3 M3.5 M20.5 M
Slightly volatile
Cash Flows Other Operating10.6 M10.1 M8.8 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.814.013215.1644
Slightly volatile
Days Sales Outstanding109104109
Slightly volatile
Stock Based Compensation To Revenue0.110.0870.1214
Slightly volatile
Capex To Depreciation5.055.0279.9131
Slightly volatile
EV To Sales4.694.934716.1932
Slightly volatile
Inventory Turnover0.690.72771.5617
Slightly volatile
Days Of Inventory On Hand527502266
Slightly volatile
Payables Turnover2.091.39762.0639
Slightly volatile
Sales General And Administrative To Revenue0.620.70.7577
Slightly volatile
Research And Ddevelopement To Revenue0.180.160.1543
Slightly volatile
Capex To Revenue0.150.14860.2983
Slightly volatile
Cash Per Share1.581.56391.1656
Slightly volatile
Days Payables Outstanding179261208
Slightly volatile
Income Quality0.941.12750.7716
Slightly volatile
Intangibles To Total Assets0.0460.03150.0572
Slightly volatile
Current Ratio2.663.06042.0459
Slightly volatile
Receivables Turnover3.073.523.4442
Slightly volatile
Graham Number6.167.04117.0021
Pretty Stable
Capex Per Share1.010.95890.5547
Pretty Stable
Revenue Per Share3.336.45122.8673
Slightly volatile
Interest Debt Per Share8.377.97393.4878
Slightly volatile
Debt To Assets0.630.70260.8871
Slightly volatile
Operating Cycle318605354
Slightly volatile
Days Of Payables Outstanding179261208
Slightly volatile
Ebt Per Ebit1.121.20851.3782
Very volatile
Long Term Debt To Capitalization0.490.91120.4061
Slightly volatile
Total Debt To Capitalization1.090.91121.7903
Slightly volatile
Quick Ratio1.941.66161.4837
Slightly volatile
Net Income Per E B T0.810.9990.9969
Slightly volatile
Cash Ratio1.240.70050.9102
Slightly volatile
Cash Conversion Cycle188344149
Slightly volatile
Days Of Inventory Outstanding527502266
Slightly volatile
Days Of Sales Outstanding109104109
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.061.27731.4696
Slightly volatile
Fixed Asset Turnover2.982.04942.7863
Slightly volatile
Debt Ratio0.630.70260.8871
Slightly volatile
Price Sales Ratio3.814.013215.1644
Slightly volatile
Asset Turnover0.540.61480.664
Very volatile
Gross Profit Margin0.480.64780.5576
Slightly volatile

Establishment Labs Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap706.4 M662.8 M632.2 M
Slightly volatile
Enterprise Value732.2 M815 M655.1 M
Slightly volatile

Establishment Fundamental Market Drivers

Cash And Short Term Investments40 M

Establishment Upcoming Events

26th of February 2024
Upcoming Quarterly Report
View
13th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Establishment Labs Financial Statements

Establishment Labs stakeholders use historical fundamental indicators, such as Establishment Labs' revenue or net income, to determine how well the company is positioned to perform in the future. Although Establishment Labs investors may analyze each financial statement separately, they are all interrelated. For example, changes in Establishment Labs' assets and liabilities are reflected in the revenues and expenses on Establishment Labs' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Establishment Labs Holdings. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue1.8 M1.5 M
Total Revenue165.2 M92 M
Cost Of Revenue58.2 M34 M
Stock Based Compensation To Revenue 0.09  0.11 
Sales General And Administrative To Revenue 0.70  0.62 
Research And Ddevelopement To Revenue 0.16  0.18 
Capex To Revenue 0.15  0.15 
Revenue Per Share 6.45  3.33 
Ebit Per Revenue(0.39)(0.41)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Establishment Labs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Establishment Labs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Establishment Labs Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Establishment Labs Holdings Stock:
Check out the analysis of Establishment Labs Correlation against competitors.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Establishment Labs. If investors know Establishment will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Establishment Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.59)
Revenue Per Share
5.58
Quarterly Revenue Growth
0.045
Return On Assets
(0.12)
Return On Equity
(2.23)
The market value of Establishment Labs is measured differently than its book value, which is the value of Establishment that is recorded on the company's balance sheet. Investors also form their own opinion of Establishment Labs' value that differs from its market value or its book value, called intrinsic value, which is Establishment Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Establishment Labs' market value can be influenced by many factors that don't directly affect Establishment Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Establishment Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Establishment Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Establishment Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.